02722nam 2200625 a 450 991077928950332120200520144314.00-309-22557-41-280-38023-397866135581450-309-22555-8(CKB)2550000000102948(SSID)ssj0000648372(PQKBManifestationID)11442402(PQKBTitleCode)TC0000648372(PQKBWorkID)10617186(PQKB)11695043(MiAaPQ)EBC3378973(Au-PeEL)EBL3378973(CaPaEBR)ebr10557792(CaONFJC)MIL355814(OCoLC)923287520(EXLCZ)99255000000010294820120517d2012 uy 0engurcn|||||||||txtccrAlzheimer's diagnostic guideline validation[electronic resource] exploration of next steps : workshop summary /Diane E. Pankevich, Theresa Wizemann, and Bruce M. Altevogt, rapporteurs ; Forum on Neuroscience and Nervous System Disorders ; Board on Health Sciences Policy, Institute of Medicine of the National AcademiesWashington, D.C. National Academies Press2012xi, 26 p. illBibliographic Level Mode of Issuance: Monograph0-309-22554-X Includes bibliographical references."Scientific advances during the last decade now indicate that Alzheimer's disease is a continuous, progressive cognitive disease, most likely beginning many years before dementia is apparent. To discuss the next steps in validating new diagnostic guidelines for Alzheimer's disease, the IOM Forum on Neuroscience and Nervous System Disorders hosted a public workshop session at the Alzheimer's Association International Conference."--Publisher's description.Alzheimer's diseaseResearchCongressesAlzheimer's diseaseTreatmentCongressesDiagnostic imagingCongressesAlzheimer's diseaseResearchAlzheimer's diseaseTreatmentDiagnostic imaging616.8/31Pankevich Diane E1534857Wizemann Theresa M890630Altevogt Bruce M1478507Institute of Medicine (U.S.).Forum on Neuroscience and Nervous System Disorders.Institute of Medicine (U.S.).Board on Health Sciences Policy.MiAaPQMiAaPQMiAaPQBOOK9910779289503321Alzheimer's diagnostic guideline validation3782695UNINA